An Israeli hospital appears to have invented an experimental cancer treatment which is showing remission in 90% of myeloma cancers.
An experimental cancer treatment developed in Israel has become so effective for an incurable form of cancer, the hospital administering it has a waiting list more than 6 months long.
Oncologists at the immunology department at Hadassah University Medical Center in Jerusalem used the revolutionary CAR-T, or Chimeric Antigen Receptor T-Cell Therapy, to achieve remission of multiple myeloma in 90% of the 74 patients who undertook the experimental treatment.
As someone who’s been fighting skin cancer, I think this is an extraordinary step toward finding a cure.
The way this particular CAR-T cell therapy treatment works is by taking donated blood and separating out the red blood cells from the white blood cells. Then, a genetic engineering procedure is undertaken in which a deactivated virus is filled with the necessary signals to train the white blood cells, in particular the immune weapon known as a T cell, how to target the cancer tumors.
Hadassah is actually the second institution to make headlines recently over a multiple myeloma CAR-T cell treatment. GNN reported on the development at a state-run hospital in Barcelona in 2021 that achieved a 75% remission rate.
It certainly appears we are getting closer to eradicating cancer, and while we’re not there yet, there are great things coming out of these hospitals.